OM
Opaleye Management’s Fennec Pharmaceuticals FENC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-272,200
| Closed | -$2.61M | – | 44 |
|
2022
Q4 | $2.61M | Buy |
+272,200
| New | +$2.61M | 0.91% | 32 |
|
2020
Q3 | – | Sell |
-171,000
| Closed | -$1.43M | – | 62 |
|
2020
Q2 | $1.43M | Buy |
+171,000
| New | +$1.43M | 0.29% | 43 |
|
2020
Q1 | – | Sell |
-12,000
| Closed | -$78K | – | 47 |
|
2019
Q4 | $78K | Buy |
+12,000
| New | +$78K | 0.02% | 45 |
|
2019
Q3 | – | Sell |
-295,000
| Closed | -$1.18M | – | 52 |
|
2019
Q2 | $1.18M | Sell |
295,000
-335,000
| -53% | -$1.34M | 0.36% | 38 |
|
2019
Q1 | $3.06M | Sell |
630,000
-270,000
| -30% | -$1.31M | 0.85% | 41 |
|
2018
Q4 | $5.74M | Sell |
900,000
-75,000
| -8% | -$479K | 2.14% | 15 |
|
2018
Q3 | $8M | Buy |
975,000
+30,000
| +3% | +$246K | 2.03% | 17 |
|
2018
Q2 | $9.87M | Buy |
945,000
+72,000
| +8% | +$752K | 2.55% | 11 |
|
2018
Q1 | $10.6M | Buy |
873,000
+26,100
| +3% | +$316K | 3.02% | 9 |
|
2017
Q4 | $8.49M | Buy |
+846,900
| New | +$8.49M | 2.72% | 12 |
|